Rosetta Genomics, Marina Biotech Form microRNA Alliance | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Rosetta Genomics and RNA drug developer Marina Biotech today announced that they have forged a microRNA diagnostics and drug discovery and development alliance, focusing on neuromuscular diseases and dystrophies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.